The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Kurt Huber

Showing 1-13 of 13 articles
Coronary interventions
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: A CULPRIT-SHOCK angiographic substudy
Overtchouk P, Barthelemy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J-P, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G, Bertin B, Brugier D, Vignolles N, Hage G, El Kasty M, Kerneis M, Huber K, Sandri M, Noc M, Fuernau G
July 7, 2020 | 10.4244/EIJ-D-20-00139
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Chieffo A, Stefanini G, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan G, Gilard M, Halvorsen S, Huber K, James S, Neumann F, Möllmann H, Roffi M, Tavazzi G, Ferré J, Windecker S, Dudek D, Baumbach A
June 25, 2020 | 10.4244/EIJY20M05_01
Coronary interventions
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes
Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys P, Hamm C, Steg P, Heg D, Branca M, Jüni P, Windecker S, Valgimigli M, Benit E, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Liebetrau C
June 2, 2020 | 10.4244/EIJ-D-20-00145
Coronary interventions
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
Fabris E, van’t Hof A, Hamm C, Lapostolle F, Flensted Lassen J, Goodman S, ten Berg J, Bolognese L, Cequier A, Chettibi M, Hammett C, Huber K, Janzon M, Merkely B, Storey R, Zeymer U, Cantor W, Rousseau H, Vicaut E, Montalescot G
May 15, 2017 | 10.4244/EIJ-D-16-00965
Coronary interventions
Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified
Huber K, Verheugt F
March 20, 2017 | 10.4244/EIJV12I16A315
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J-P, Valgimigli M, Byrne R
January 22, 2015 | 10.4244/EIJV10I9A174
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
Gorenek B, Blomström-Lundqvist C, Terradellas J, Camm A, Hindricks G, Huber K, Kirchhof P, Kuck K, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz R, Valgimigli M, Vos M, Vrints C, Zeymer U, Kristiansen S
January 22, 2015
An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents
Katsaros K, Kastl S, Krychtiuk K, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl W
June 20, 2014 | 10.4244/EIJV10I2A36
Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology
Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, Sabate M, Mauri-Ferre J, Huber K, Niemela K, Haude M, Wijns W, Dudek D, Fajadet J, Kiemeneij F
March 22, 2013 | 10.4244/EIJV8I11A192
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation
De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A
August 24, 2012 | 10.4244/EIJV8I4A74
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update
Cuisset T, Valgimigli M, Mudra H, Mueller O, Wijns W, Huber K
May 25, 2010
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions
Cuisset T, Mudra H, Mueller O, Vogt P, Angelillo-Scherrer A, Huber K
August 20, 2008
Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry
Suessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, Weidinger F
August 20, 2008

Latest news

NEW ISSUE
CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR
August 7, 2020
NEW
Ahead of Print: Coronary Artery Thrombosis in COVID-19
August 7, 2020
Editorial
Coronary collaterals, the natural grafts of CTO lesions
C. Di Mario
August 7, 2020
PCR Trials
TWILIGHT, ONYX ONE, DKCRUSH-V and much more
(The Trials book is supported by Biotronik)
August 11, 2020
Guidance Papers
Guidelines, consensus & position papers
June 25, 2020
Editorial
Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success
JM De la Torre Hernandez
August 7, 2020
JAA
This Week's JAA's: Real-world Use of the Evolut PRO Valve...
August 4, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke